Zhong and colleagues found that YTHDF2 represses cell proliferation and growth in HCC and functions as a HCC tumor suppressor via destabilizing EGFR transcript (Zhong et al. 2019). Here, YTHDF2 is linked to hepatocellular carcinoma.